Vaccine Sales and New Variants Create Alarm
Recently, there’s been chatter about vaccine sales lagging, particularly with figures like President Trump and RFK Jr. at the forefront. The relationship between large pharmaceutical companies and the government seems to be fraying as new COVID-19 variants emerge and regain media attention.
One variant in particular—dubbed razor blade throat—is drawing concern. It’s difficult not to find this naming a bit dramatic, right? The phrase alone triggers a sense of panic. And honestly, it feels like designed to ramp up fear and promote vaccine sales.
Isn’t it interesting? Just when you think we’ve reached a lull, another mutation or virus appears on the scene. COVID-19 hasn’t vanished completely; meanwhile, there are moments when monkeypox and RSV steal the spotlight, and bird flu has shown its face too.
The World Health Organization maintains that the global risks aren’t high, which, considering the situation, is somewhat reassuring. They also mention that current vaccines are still holding up, although the effectiveness is a point of debate.
Some experts have labeled the new variants as “surveillance variants,” indicating they don’t pose a significant threat, but vaccines are still expected to be effective.
It’s not the end of the world, but we’re still dealing with a challenging strain of the virus that’s been around for years. Dr. Peter McCullough suggests staying proactive. “Using nasal sprays can really help,” he notes, offering a straightforward strategy to minimize viral loads and prevent infections before they start.
It feels familiar, doesn’t it? We’ve been through similar scares before, yet this time, there’s a sense that we shouldn’t rely on the conventional narratives pushed by media and pharmaceutical companies.
They want us to be anxious, to feel uneasy. But really, is there any reason to succumb to that fear?
As Dr. McCullough wisely said, “I’m not going to just sit back and wait for the government to dictate my choices.”
This perspective aligns with the emergence of the Wellness Company, which has introduced the Contagious Emergency Kit—a product created by Dr. McCullough and colleagues. It contains several essential prescription medications, including generic Tamiflu™, ivermectin, and hydroxychloroquine.
- Oseltamivir 75 mg (Generic Tamiflu™) – 10 tablets
- Hydroxychloroquine 200 mg – 20 tablets
- Ivermectin 12mg – 25 tablets
- Azithromycin (Generic Z-PAK) 250 mg – 12 tablets
- Budesonide 0.5 mg/2 ml – 5 vials (nebulizer included)
- A user guide drafted by the Chief Medical Committee.
Why not have effective medications on hand alongside your usual Tylenol and NyQuil? The Infectious Emergency Kit stands out as a reliable choice for preparation.
Keep in mind, this kit is available by prescription only and isn’t sold in stores. A quick questionnaire is required after purchase, ensuring a healthcare provider reviews your suitability before issuing a prescription.
Don’t let these critical medications gather dust in your cabinet. Safeguard your family by acquiring the Wellness Company Contagion Kit before another emergency strikes!
Hope isn’t a strategy for the coming year; taking proactive steps today is what really counts.
“This kit is invaluable—it’s something every home should have for peace of mind.” – Rebecca B
“This is absolutely a must-have for emergencies!” – Melody H.
“I feel so relieved having this kit in my home. It arrived just in time!” – Phyllis T.
Don’t hesitate—order the Wellness Company’s Contagion Kit today.
Note: The information provided here is for informational purposes only. It shouldn’t replace professional healthcare advice or guidance regarding prescription medications.
